Dr. George is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
100 Stokes Street, CAMH
BGB 3288
New Haven, CT 06510Phone+1 416-535-8501Fax+1 416-260-4171- Is this information wrong?
Education & Training
- Yale-New Haven Medical CenterInternship, Transitional Year, 1992 - 1993
- Dalhousie University Faculty of MedicineClass of 1992
Certifications & Licensure
- CT State Medical License 1994 - 2014
Clinical Trials
- Treating Nicotine Dependence in Schizophrenic Individuals: Effectiveness of Bupropion - 1 Start of enrollment: 2001 Sep 01
- Usefulness of Selegiline as an Aid to Quit Smoking - 1 Start of enrollment: 2004 Jul 01
- Nicotinic Receptor Augmentation of SSRI Antidepressants Start of enrollment: 2003 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 36 citationsEvaluating the temporal relationships between withdrawal symptoms and smoking relapseJason D. Robinson, Liang Li, Minxing Chen, Caryn Lerman, Rachel F. Tyndale
Psychology of Addictive Behaviors. 2019-01-07 - 21 citationsEffects of galantamine on cognitive deficits in smokers and non-smokers with schizophrenia.Kristi A. Sacco, Cerissa L. Creeden, Erin L. Reutenauer, Tony P. George
Schizophrenia Research. 2008-08-01 - 136 citationsA review of co-morbid tobacco and cannabis use disorders: possible mechanisms to explain high rates of co-use.Rachel A. Rabin, Tony P. George
The American Journal on Addictions. 2015-03-01
Press Mentions
- The Lancet Psychiatry: Novel Approach for the Treatment of Cannabis Use Disorder Shows Promise in Phase 2 TrialDecember 6th, 2018
- Legal Cannabis Is Coming. Let’s Make Sure We’re Educated About the RisksMarch 14th, 2018
- Battling Prescription Drug Addiction After an Injury? You Are Not AloneMay 22nd, 2017
- Join now to see all
Grant Support
- Translational Studies On Smoking In SchizophreniaNational Institute On Drug Abuse2004–2006
- Selegiline For Smoking CessationNational Institute On Drug Abuse2004–2006
- Optimizing Treatment For Schizophrenic SmokersNational Institute On Drug Abuse2001–2004
- Nicotinic Receptors And COG Function In SchizophreniaNational Institute On Drug Abuse2001–2003
- Pilot Study--Selegiline For Smoking CessationNational Institute On Drug Abuse1999–2002
- Gabaergic &Glutamatergic Agents--Cocaine Use In Methadone MaintenanceNational Institute On Drug Abuse1999–2002
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: